Please Wait.....
Report
India Prosthetic Heart Valve Market By Product (Tissue Heart Valve, Mechanical Heart Valve, Transcatheter Heart Valve) , : Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-10-01 I 90 Pages I Allied Market Research
India Prosthetic Heart Valve Market
The India prosthetic heart valve market was valued at $159.9 million in 2023 and is projected to reach $519.7 million by 2033, growing at a CAGR of 12.5% from 2024 to 2033.
A prosthetic heart valve is an artificial instrument designed to substitute the impaired native valves of the human heart. Its efficient opening and closing at every heartbeat promote effective blood circulation throughout the body. Prosthetic valves are majorly of two types: bioprosthetic and mechanical. Bioprosthetic valves are developed using biological tissues derived from animals or humans and mechanical valves are fabricated from durable materials such as titanium or carbon. The longevity of these devices typically ranges from 20 to 30 years, minimizing the risk of blood clot formation on their surfaces.
The exponentially aging population in India is a key driver of the market as elderly individuals remain highly susceptible to cardiovascular diseases. In addition, upsurge in sedentary lifestyles and unhealthy dietary habits has increased the prevalence of heart diseases in middle-aged individuals, thereby propelling the development of the market. Furthermore, the implementation of several initiatives by the government to improve healthcare infrastructure and promote the affordability of treatments & medications is projected to fuel the demand for prosthetic heart valves in coming years. A notable trend gaining prominence in the India prosthetic heart valve market is the use of 3D printing technology for the development of the valves. They are created using specialized biopolymers with high biocompatibility and customization ability, eliminating the risks associated with existing synthetic valves such as thrombotic and thromboembolic complications.
However, shortage of efficient doctors and manpower hinders the effective and timely delivery of healthcare in India. This exhibits an impact on the requirement for prosthetic heart valves and restrains the growth of the market. Moreover, lack of efficient resources and infrastructure in the remote locations of India limits the utility of valves, hampering the market development significantly. On the contrary, rise in medical tourism in the country due to the availability of advanced medical technologies in urban settings is anticipated to present lucrative opportunities for the India prosthetic heart valve market. According to EY, a British accounting firm, the number of medical tourists visiting India crossed the mark of 0.5 million in 2023. This number is further projected to increase in the future and open new avenues for the market.
Segment Review
The India prosthetic heart valve market is segmented by product. On the basis of product, the market is divided into tissue heart valve, mechanical heart valve, and transcatheter heart valve.
Key Findings
On the basis of product, the transcatheter heart valve segment held a high share of the market in 2023.
Competition Analysis
The leading players operating in the global India prosthetic heart valve market include Edwards Lifesciences Corporation, TTK, SMT, Relisys Medical Devices Limited, Medtronic, Heart Care India Co., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., P+F Products + Features GmbH, Abbott Laboratories, and NeoCor CJSC. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
- Tissue Heart Valve
- Stented Tissue Heart Valve
- Stentless Tissue Heart Valve
- Mechanical Heart Valve
- Transcatheter Heart Valve
- Key Market Players
- Edwards Lifesciences Corporation
- TTK
- SMT
- Relisys Medical Devices Limited.
- Medtronic
- Heart Care India Co
- Boston Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- P+F Products + Features GmbH
- Abbott Laboratories
- NeoCor CJSC
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Tissue Heart Valve
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Stented Tissue Heart Valve
4.2.3. Stentless Tissue Heart Valve
4.3. Mechanical Heart Valve
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.4. Transcatheter Heart Valve
4.4.1. Key Market Trends, Growth Factors and Opportunities
CHAPTER 5: COMPETITIVE LANDSCAPE
5.1. Introduction
5.2. Top Winning Strategies
5.3. Product Mapping Of Top 10 Player
5.4. Competitive Dashboard
5.5. Competitive Heatmap
5.6. Top Player Positioning,2023
CHAPTER 6: COMPANY PROFILES
6.1. Edwards Lifesciences Corporation
6.1.1. Company Overview
6.1.2. Key Executives
6.1.3. Company Snapshot
6.1.4. Operating Business Segments
6.1.5. Product Portfolio
6.1.6. Business Performance
6.1.7. Key Strategic Moves and Developments
6.2. TTK
6.2.1. Company Overview
6.2.2. Key Executives
6.2.3. Company Snapshot
6.2.4. Operating Business Segments
6.2.5. Product Portfolio
6.2.6. Business Performance
6.2.7. Key Strategic Moves and Developments
6.3. SMT
6.3.1. Company Overview
6.3.2. Key Executives
6.3.3. Company Snapshot
6.3.4. Operating Business Segments
6.3.5. Product Portfolio
6.3.6. Business Performance
6.3.7. Key Strategic Moves and Developments
6.4. Relisys Medical Devices Limited.
6.4.1. Company Overview
6.4.2. Key Executives
6.4.3. Company Snapshot
6.4.4. Operating Business Segments
6.4.5. Product Portfolio
6.4.6. Business Performance
6.4.7. Key Strategic Moves and Developments
6.5. Medtronic
6.5.1. Company Overview
6.5.2. Key Executives
6.5.3. Company Snapshot
6.5.4. Operating Business Segments
6.5.5. Product Portfolio
6.5.6. Business Performance
6.5.7. Key Strategic Moves and Developments
6.6. Heart Care India Co
6.6.1. Company Overview
6.6.2. Key Executives
6.6.3. Company Snapshot
6.6.4. Operating Business Segments
6.6.5. Product Portfolio
6.6.6. Business Performance
6.6.7. Key Strategic Moves and Developments
6.7. Boston Scientific Corporation
6.7.1. Company Overview
6.7.2. Key Executives
6.7.3. Company Snapshot
6.7.4. Operating Business Segments
6.7.5. Product Portfolio
6.7.6. Business Performance
6.7.7. Key Strategic Moves and Developments
6.8. Meril Life Sciences Pvt. Ltd.
6.8.1. Company Overview
6.8.2. Key Executives
6.8.3. Company Snapshot
6.8.4. Operating Business Segments
6.8.5. Product Portfolio
6.8.6. Business Performance
6.8.7. Key Strategic Moves and Developments
6.9. P+F Products + Features GmbH
6.9.1. Company Overview
6.9.2. Key Executives
6.9.3. Company Snapshot
6.9.4. Operating Business Segments
6.9.5. Product Portfolio
6.9.6. Business Performance
6.9.7. Key Strategic Moves and Developments
6.10. Abbott Laboratories
6.10.1. Company Overview
6.10.2. Key Executives
6.10.3. Company Snapshot
6.10.4. Operating Business Segments
6.10.5. Product Portfolio
6.10.6. Business Performance
6.10.7. Key Strategic Moves and Developments
6.11. NeoCor CJSC
6.11.1. Company Overview
6.11.2. Key Executives
6.11.3. Company Snapshot
6.11.4. Operating Business Segments
6.11.5. Product Portfolio
6.11.6. Business Performance
6.11.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($MILLION)
TABLE 2. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 3. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 4. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 5. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 6. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 7. TTK: KEY EXECUTIVES
TABLE 8. TTK: COMPANY SNAPSHOT
TABLE 9. TTK: OPERATING SEGMENTS
TABLE 10. TTK: PRODUCT PORTFOLIO
TABLE 11. TTK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 12. SMT: KEY EXECUTIVES
TABLE 13. SMT: COMPANY SNAPSHOT
TABLE 14. SMT: OPERATING SEGMENTS
TABLE 15. SMT: PRODUCT PORTFOLIO
TABLE 16. SMT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 17. RELISYS MEDICAL DEVICES LIMITED.: KEY EXECUTIVES
TABLE 18. RELISYS MEDICAL DEVICES LIMITED.: COMPANY SNAPSHOT
TABLE 19. RELISYS MEDICAL DEVICES LIMITED.: OPERATING SEGMENTS
TABLE 20. RELISYS MEDICAL DEVICES LIMITED.: PRODUCT PORTFOLIO
TABLE 21. RELISYS MEDICAL DEVICES LIMITED.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 22. MEDTRONIC: KEY EXECUTIVES
TABLE 23. MEDTRONIC: COMPANY SNAPSHOT
TABLE 24. MEDTRONIC: OPERATING SEGMENTS
TABLE 25. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 26. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 27. HEART CARE INDIA CO: KEY EXECUTIVES
TABLE 28. HEART CARE INDIA CO: COMPANY SNAPSHOT
TABLE 29. HEART CARE INDIA CO: OPERATING SEGMENTS
TABLE 30. HEART CARE INDIA CO: PRODUCT PORTFOLIO
TABLE 31. HEART CARE INDIA CO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 32. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 33. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 34. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 35. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 36. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 37. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 38. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 39. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
TABLE 40. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 41. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 42. P+F PRODUCTS + FEATURES GMBH: KEY EXECUTIVES
TABLE 43. P+F PRODUCTS + FEATURES GMBH: COMPANY SNAPSHOT
TABLE 44. P+F PRODUCTS + FEATURES GMBH: OPERATING SEGMENTS
TABLE 45. P+F PRODUCTS + FEATURES GMBH: PRODUCT PORTFOLIO
TABLE 46. P+F PRODUCTS + FEATURES GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 47. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 48. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 49. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 50. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 51. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 52. NEOCOR CJSC: KEY EXECUTIVES
TABLE 53. NEOCOR CJSC: COMPANY SNAPSHOT
TABLE 54. NEOCOR CJSC: OPERATING SEGMENTS
TABLE 55. NEOCOR CJSC: PRODUCT PORTFOLIO
TABLE 56. NEOCOR CJSC: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. INDIA PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 2. SEGMENTATION OF INDIA PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN INDIA PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: INDIA PROSTHETIC HEART VALVE MARKET
FIGURE 10. INDIA PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($MILLION)
FIGURE 11. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 12. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 13. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 14. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 15. COMPETITIVE DASHBOARD
FIGURE 16. COMPETITIVE HEATMAP: INDIA PROSTHETIC HEART VALVE MARKET
FIGURE 17. TOP PLAYER POSITIONING,2023
FIGURE 18. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 19. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 20. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 21. TTK: NET SALES, 2021-2023 ($MILLION)
FIGURE 22. TTK: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 23. TTK: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 24. SMT: NET SALES, 2021-2023 ($MILLION)
FIGURE 25. SMT: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. SMT: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. RELISYS MEDICAL DEVICES LIMITED.: NET SALES, 2021-2023 ($MILLION)
FIGURE 28. RELISYS MEDICAL DEVICES LIMITED.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. RELISYS MEDICAL DEVICES LIMITED.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. MEDTRONIC: NET SALES, 2021-2023 ($MILLION)
FIGURE 31. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. HEART CARE INDIA CO: NET SALES, 2021-2023 ($MILLION)
FIGURE 34. HEART CARE INDIA CO: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. HEART CARE INDIA CO: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 37. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($MILLION)
FIGURE 40. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. P+F PRODUCTS + FEATURES GMBH: NET SALES, 2021-2023 ($MILLION)
FIGURE 43. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($MILLION)
FIGURE 46. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. NEOCOR CJSC: NET SALES, 2021-2023 ($MILLION)
FIGURE 49. NEOCOR CJSC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. NEOCOR CJSC: REVENUE SHARE, BY REGION, 2023 (%)
LIST OF TABLES
TABLE 1. INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($MILLION)
TABLE 2. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 3. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 4. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 5. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 6. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 7. TTK: KEY EXECUTIVES
TABLE 8. TTK: COMPANY SNAPSHOT
TABLE 9. TTK: OPERATING SEGMENTS
TABLE 10. TTK: PRODUCT PORTFOLIO
TABLE 11. TTK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 12. SMT: KEY EXECUTIVES
TABLE 13. SMT: COMPANY SNAPSHOT
TABLE 14. SMT: OPERATING SEGMENTS
TABLE 15. SMT: PRODUCT PORTFOLIO
TABLE 16. SMT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 17. RELISYS MEDICAL DEVICES LIMITED.: KEY EXECUTIVES
TABLE 18. RELISYS MEDICAL DEVICES LIMITED.: COMPANY SNAPSHOT
TABLE 19. RELISYS MEDICAL DEVICES LIMITED.: OPERATING SEGMENTS
TABLE 20. RELISYS MEDICAL DEVICES LIMITED.: PRODUCT PORTFOLIO
TABLE 21. RELISYS MEDICAL DEVICES LIMITED.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 22. MEDTRONIC: KEY EXECUTIVES
TABLE 23. MEDTRONIC: COMPANY SNAPSHOT
TABLE 24. MEDTRONIC: OPERATING SEGMENTS
TABLE 25. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 26. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 27. HEART CARE INDIA CO: KEY EXECUTIVES
TABLE 28. HEART CARE INDIA CO: COMPANY SNAPSHOT
TABLE 29. HEART CARE INDIA CO: OPERATING SEGMENTS
TABLE 30. HEART CARE INDIA CO: PRODUCT PORTFOLIO
TABLE 31. HEART CARE INDIA CO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 32. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 33. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 34. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 35. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 36. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 37. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 38. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 39. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
TABLE 40. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 41. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 42. P+F PRODUCTS + FEATURES GMBH: KEY EXECUTIVES
TABLE 43. P+F PRODUCTS + FEATURES GMBH: COMPANY SNAPSHOT
TABLE 44. P+F PRODUCTS + FEATURES GMBH: OPERATING SEGMENTS
TABLE 45. P+F PRODUCTS + FEATURES GMBH: PRODUCT PORTFOLIO
TABLE 46. P+F PRODUCTS + FEATURES GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 47. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 48. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 49. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 50. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 51. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 52. NEOCOR CJSC: KEY EXECUTIVES
TABLE 53. NEOCOR CJSC: COMPANY SNAPSHOT
TABLE 54. NEOCOR CJSC: OPERATING SEGMENTS
TABLE 55. NEOCOR CJSC: PRODUCT PORTFOLIO
TABLE 56. NEOCOR CJSC: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. INDIA PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 2. SEGMENTATION OF INDIA PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN INDIA PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: INDIA PROSTHETIC HEART VALVE MARKET
FIGURE 10. INDIA PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($MILLION)
FIGURE 11. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 12. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 13. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 14. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 15. COMPETITIVE DASHBOARD
FIGURE 16. COMPETITIVE HEATMAP: INDIA PROSTHETIC HEART VALVE MARKET
FIGURE 17. TOP PLAYER POSITIONING,2023
FIGURE 18. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 19. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 20. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 21. TTK: NET SALES, 2021-2023 ($MILLION)
FIGURE 22. TTK: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 23. TTK: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 24. SMT: NET SALES, 2021-2023 ($MILLION)
FIGURE 25. SMT: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. SMT: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. RELISYS MEDICAL DEVICES LIMITED.: NET SALES, 2021-2023 ($MILLION)
FIGURE 28. RELISYS MEDICAL DEVICES LIMITED.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. RELISYS MEDICAL DEVICES LIMITED.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. MEDTRONIC: NET SALES, 2021-2023 ($MILLION)
FIGURE 31. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. HEART CARE INDIA CO: NET SALES, 2021-2023 ($MILLION)
FIGURE 34. HEART CARE INDIA CO: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. HEART CARE INDIA CO: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 37. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($MILLION)
FIGURE 40. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. P+F PRODUCTS + FEATURES GMBH: NET SALES, 2021-2023 ($MILLION)
FIGURE 43. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($MILLION)
FIGURE 46. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. NEOCOR CJSC: NET SALES, 2021-2023 ($MILLION)
FIGURE 49. NEOCOR CJSC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. NEOCOR CJSC: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security